Randomized Trial in Adult de Novo Ph Positive ALL With Chemotherapy, Imatinib or Ponatinib, Blinatumomab and SCT

Key facts

Sponsor

Goethe University

Principal Investigator

Nicola Goekbuget, MD

Department of Medicine, Hematology and Oncology, Goethe University Frankfurt, Frankfurt, Germany

Intervention

Imatinib(drug)

Enrollment

220 enrolled

Eligibility

18-65 years · All sexes

Timeline

2023 – 2029

Study locations (30)

• Uniklinik RWTH Aachen, Aachen, Germany
• Klinikum Aschaffenburg, Aschaffenburg, Germany
• Klinikum Augsburg, Augsburg, Germany
• Helios Klinikum Bad Saarow, Bad Saarow, Germany
• Klinikum Bayreuth, Bayreuth, Germany
• Vivantes Klinikum am Urban, Berlin, Germany
• Charité Universitätsmedizin Berlin, Berlin, Germany
• Vivantes Klinikum Neukölln, Berlin, Germany
• Helios Klinikum Berlin-Buch, Berlin, Germany
• Charite Berlin Virchow Klinikum, Berlin, Germany
• Evangelisches Krankenhaus Bielefeld, Bielefeld, Germany
• UK Knappschaftskrankenhaus Bochum, Bochum, Germany
• Evangelische Kliniken Bonn, Bonn, Germany
• Universitätsklinikum Bonn, Bonn, Germany
• Städtisches Klinikum Braunschweig, Braunschweig, Germany
• +15 more locations on ClinicalTrials.gov

Collaborators

Deutsche Leukämie- & Lymphom-Hilfe · German Federal Ministry of Education and Research

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Acute lymphoblastic leukemia

Additional recruiting or active studies for the same condition.

• RECRUITINGNANCT05621291
  A Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring of B-cell Recovery to Guide Management Following Chimeric Antigen Receptor T-cell (CART) Induced Remission in Children and Young Adults With B Lineage Acute Lymphoblastic Leu...
  National Cancer Institute (NCI)
• ENROLLING BY INVITATIONNCT07511959
  Autologous Exosomes From Platelet-rich Plasma as a Modern Tool of Regenerative Dentistry
  Wroclaw Medical University
• RECRUITINGPHASE2NCT06738368
  Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (DA-EPOCH) With or Without Rituximab Plus Recombinant Erwinia Asparaginase (JZP458) for the Treatment of Newly Diagnosed Ph Negative B-Acute Lymphoblastic Leukemia or T Acute Lymphoblastic Leukemia
  University of Washington
• RECRUITINGNANCT07191119
  Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia
  St. Jude Children's Research Hospital
• RECRUITINGPHASE2NCT07275762
  Y-4 to Treat the Postherpetic Neuralgia
  Neurodawn Pharmaceutical Co., Ltd.
• RECRUITINGNANCT07177183
  Low Serum Creatinine as a Predictor of Prolonged Mechanical Ventilation and Weaning Failure
  University Hospital Ostrava
• RECRUITINGNANCT07201974
  Virtual Reality for Post-Stroke Gait Rehabilitation
  McGill University
• ENROLLING BY INVITATIONNCT07515430
  The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic Leukemia
  Sun Yat-sen University

See all trials for Acute lymphoblastic leukemia →